The country’s first case of blood clotting from the AstraZeneca vaccine was reported today(Tuesday).
The Public Health Agency of Canada received a report of an individual living in Canada who experienced a very rare adverse event involving blood clots with low platelets.
This person is now at home recovering and has taken the COVISHIELD version of the vaccine.
- Advertisement -
In March health Canada said the Astrazeneca vaccine could not be given to adults under the age of 55 because of concerns of blood clotting.